five successful manufacturing runs completed for CDH17. Which means that five patients will be dosed in the near term.
CDH17 trial is powering ahead. CEO mentioned that big pharma were keenly watching the prelim data for the (six) patients.
will hopefully get prelim data from the first 3 patients soon.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

five successful manufacturing runs completed for CDH17. Which...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $100 | 25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 21874000 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 19510638 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 21874000 | 0.004 |
37 | 23631939 | 0.003 |
15 | 13500507 | 0.002 |
9 | 49600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 19510638 | 27 |
0.006 | 23500718 | 17 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
0.009 | 2767672 | 5 |
Last trade - 15.25pm 17/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online